W, X., A, L., E, F., C, R., R, P., & K, B. (2019). A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in Germany. International journal of women's health, 11, 319. https://doi.org/10.2147/IJWH.S193048
Chicago Style (17th ed.) CitationW, Xue, Lloyd A, Falla E, Roeder C, Papsch R, and Bühler K. "A Cost-effectiveness Evaluation of the Originator Follitropin Alpha Compared to the Biosimilars for Assisted Reproduction in Germany." International Journal of Women's Health 11 (2019): 319. https://doi.org/10.2147/IJWH.S193048.
MLA (9th ed.) CitationW, Xue, et al. "A Cost-effectiveness Evaluation of the Originator Follitropin Alpha Compared to the Biosimilars for Assisted Reproduction in Germany." International Journal of Women's Health, vol. 11, 2019, p. 319, https://doi.org/10.2147/IJWH.S193048.